The findings of the present study imply that many breast cancers not only fail to recruit DC but fail to drive DC into either the antigen capture/processing phase (CD1a+) or the antigen presentation/co-stimulatory phase (CMRF-44/56+). This evidence concerns the gene CD1A and breast carcinoma.